Bayesian Networks to Support Decision-Making for Immune-Checkpoint Blockade in Recurrent/Metastatic (R/M) Head and Neck Squamous Cell Carcinoma (HNSCC)
New diagnostic methods and novel therapeutic agents spawn additional and heterogeneous information, leading to an increasingly complex decision-making process for optimal treatment of cancer. A great amount of information is collected in organ-specific multidisciplinary tumor boards (MDTBs). By cons...
Main Authors: | Marius Huehn, Jan Gaebel, Alexander Oeser, Andreas Dietz, Thomas Neumuth, Gunnar Wichmann, Matthaeus Stoehr |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-11-01
|
Series: | Cancers |
Subjects: | |
Online Access: | https://www.mdpi.com/2072-6694/13/23/5890 |
Similar Items
-
A Comprehensive Benchmark of Transcriptomic Biomarkers for Immune Checkpoint Blockades
by: Hongen Kang, et al.
Published: (2023-08-01) -
A Treatment Decision Support Model for Laryngeal Cancer Based on Bayesian Networks
by: Aisha Hikal, et al.
Published: (2023-01-01) -
The Chemokines Initiating and Maintaining Immune Hot Phenotype Are Prognostic in ICB of HNSCC
by: Yuhong Huang, et al.
Published: (2022-05-01) -
Immune checkpoint inhibition mediated with liposomal nanomedicine for cancer therapy
by: Guang-Long Ma, et al.
Published: (2023-04-01) -
Immune responses to SARS-CoV-2 in vaccinated patients receiving checkpoint blockade immunotherapy for cancer
by: Alexander Piening, et al.
Published: (2022-12-01)